HIV and ID Observations

October 31st, 2021

Interesting and Important Studies from IAS 2021 and IDWeek That Caught My Eye

As noted in my previous post, attending virtual meetings poses some serious challenges. The biggest obstacle:  trying to do one’s regular job while periodically checking in (or more likely not checking in) on the meeting. And while I might have been able to pull off some Really Rapid Reviews© after a few virtual meetings, not so […]

---

March 14th, 2021

Really Rapid Review — CROI 2021 Virtual

For a few years in the early 2010s, the Conference on Retroviruses and Opportunistic Infections (CROI) — in my opinion our premiere HIV scientific meeting — covered almost as many hepatitis C clinical trials as those on HIV. Or at least it seemed that way. This made sense at the time — the startling success of […]

---

July 15th, 2020

Really Rapid Review — AIDS 2020 Virtual

The International AIDS Conference — or AIDS 2020 — shifted from its Bay Area dual locations of San Francisco and Oakland to be entirely online. Digital. In the cloud. Virtual. The primary motivation for the switch was to show off what the numerous tech giants in the region could do with this fancy thing called the World […]

---

March 16th, 2020

Difficult Times — Meaning No CROI Really Rapid Review 2020

In a usual year, right about now, I’d be obsessed with two things: What were the most practice-changing studies presented at the Conference on Retroviruses and Opportunistic Infections, or CROI? I’d want to summarize those for a patented, copyright-protected, check-with-my-lawyer-before-copying, Really Rapid Review©®. How will the upcoming baseball season play out? Most readers here don’t care, […]

---

July 28th, 2019

Really Rapid Review — IAS 2019 Mexico City

As I noted last week — and you did read last week’s post, didn’t you? — the International AIDS conference first took place in Mexico City in 2008. Last week we returned to this sprawling, vibrant city for the 2019 meeting. It was an excellent, well-run conference — with one small complaint. But more on that later… […]

---

March 10th, 2019

Really Rapid Review — CROI 2019 Seattle

As a foot of wet snow bore down on Boston last week — see this post for why that matters — HIV researchers and policy makers headed to Seattle for this year’s Conference on Retroviruses and Opportunistic Infections, or CROI, which took place from March 4-7. And already I was feeling the pressure, based on this […]

---

October 8th, 2018

“Mini”-Really Rapid Review — IDWeek 2018, San Francisco

Once upon a time, the annual meeting of the Infectious Diseases Society of America (IDSA) wasn’t much of a research conference. It consisted mostly of review sessions on topics deemed worthy of an update or a refresher, led by noted experts in the field. They would cite the latest literature on endocarditis, or mycoplasma, or prosthetic […]

---

July 29th, 2018

Really Rapid Review — International AIDS Conference 2018, Amsterdam

The International AIDS Conference — or “AIDS 2018” — returned to Amsterdam for the first time since 1992. It’s worth pausing, with gratitude, to remember that 26 years ago antiretroviral therapy consisted of three available drugs — zidovudine (AZT), didanosine (ddI), and zalcitabine (ddC). All were marginally effective, with limited durability and significant toxicity. In fact, the […]

---

March 11th, 2018

Really Rapid Review — CROI 2018, Boston

The 25th Conference on Retroviruses and Opportunistic Infections (CROI) just wrapped up in warm, sunny Boston. Everyone in attendance took advantage of the fine March weather to get some much-needed sun, to feel the sand between their toes, to sip a tropical drink, and to hear the latest in HIV research. Well, the last part was true […]

---

July 30th, 2017

Really Rapid Review — Paris IAS 2017

Last week, the International AIDS Society meeting returned to Paris for the first time since 2003. Yes, you and I are that old. Jeeze. Here’s a Really Rapid Review® of some of the conference highlights, roughly ordered by “cure”, prevention, treatment, and complications. As always, feel free to use the comments section for notable studies I might have missed […]

---